HSBC Upgrades Novartis to Hold, Raises Price Target to $136
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsUpgradesPrice TargetHot
HSBC analyst Rajesh Kumar upgrades Novartis (NYSE:NVS) from Reduce to Hold and raises the price target from $123 to $136.
HSBC analyst Rajesh Kumar upgrades Novartis (NYSE:NVS) from Reduce to Hold and raises the price target from $123 to $136.